Nifty50: 15,686 ▼ -85 (-0.5%)
Sensex: 52,306 ▼ -282 (-0.5%)
After a gap-up opening, the markets faced selling pressure. Out of the Nifty50, 34 stocks ended in the red. The Nifty Auto (+0.4%) was the only sectoral index that rose, while the Nifty Metal (-1.1%) and Nifty IT (-0.9%) were the top losers.
| Top gainers | Today's change |
| Maruti Suzuki | ▲ 2.2% |
| Titan | ▲ 1.4% |
| Bajaj Finserv | ▲ 1.2% |
| Top losers | Today's change |
| Adani Ports | ▼ 3.2% |
| Wipro | ▼ 2.8% |
| Divis Lab | ▼ 1.4% |
Here are the top stories of the day.
BEL posts strong Q4
- State-owned aerospace and defense electronics maker BEL reported a 31% year-on-year growth in its profit for the March quarter. During the same period, its sales rose by 18% to ₹6,757 crore.
- At the start of this fiscal, the company's order book stood at ₹53,434 crore, which is nearly four times its FY21 sales. Shares of the company rose 10.6% coupled with strong volumes, indicating strong buying interest. It has risen 34% so far this fiscal. Interestingly, foreign portfolio investors have increased stake in the company from 7.8% in June 2020 to 11.6% in March 2021.
Cipla gets USFDA nod for generic drug
- Pharma major Cipla received approval from the US Food & Drug Administration for its Arformoterol Tartrate Inhalation Solution. This generic drug is used for the treatment of lung diseases such as chronic bronchitis.
- The approved drug is a generic version of Sunovion Pharmaceuticals’ Brovana, which had reported sales of $438 million in the US for the 12-month period ending April 2021. Shares of Cipla were up 0.3% today.
IDBI Bank rises on privatisation buzz
- Shares of IDBI Bank rose 6% intraday as the government invited bids from transaction advisors and legal firms to assist in the bank’s strategic sale.
- The government and LIC—which hold 45.5% and 49.2% stake in the bank, respectively—are expected to sell their majority stake and give up management control. Last month, the bank reported an annual profit for the first time in five years at ₹1,359 crore for FY21. However, the stock pared some early gains and closed 2% higher for the day.
Sobha’s Q4 net profit shrinks
- Bengaluru-based real estate developer Sobha reported a 65% year-on-year decline in its consolidated net profit for the March quarter at ₹18 crore. The drop in profit was mainly due to a 39% decrease in revenue from operations to ₹553 crore.
- During the quarter, the company incurred land purchase cost of ₹131 crore, which was more than triple of that during the corresponding quarter last year. This led to an increase in the overall expenses. The stock was down 4.1% today and has been moving sideways since the beginning of this fiscal.
Closing bell
The markets continue to be torn between the bulls and bears, and thus lack a clear direction. However, the momentum gained in May seems to have been lost. Further, nearly all sectoral indices closed in the red today, indicating a broad-based selling pressure. It is time for traders to be nimble-footed as volatility could rise. The India VIX rose 4% today, after being subdued for the last two months.
Good to know
What is a risk-reward ratio?
The risk-reward ratio refers to the expected profit in relation to the risk taken. It tells a trader how much he or she stands to gain from the risk they are taking. For instance, assume that a trader buys a stock for ₹10 and places a stop-loss order at ₹5, with the expectation that the stock price will hit ₹20. It means they are taking the risk of losing ₹5 to make a profit of ₹10. Hence, the risk-reward ratio is 1:2. This ratio helps traders to gauge the risk in any trade and decide whether to take or simply avoid a specific trade.
We'd love your thoughts on this market recap.
Haven't tried out Upstox yet? Click here to open your account now!
To catch our latest educational videos, join our Telegram channel here.
Disclosures and Disclaimer
Investment in securities markets is subject to market risks; please read all the related documents carefully before investing. The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results. Details provided in the above newsletter are for educational purposes and should not be construed as investment advice by RKSV group. Investors should consult their investment advisor before making any investment decision.